34664612|t|18F-MK-6240 tau-PET in genetic frontotemporal dementia.
34664612|a|Tau is one of several proteins associated with frontotemporal dementia. While knowing which protein is causing a patient's disease is crucial, no biomarker currently exists for identifying tau in vivo in frontotemporal dementia. The objective of this study was to investigate the potential for the promising 18F-MK-6240 PET tracer to bind to tau in vivo in genetic frontotemporal dementia. We enrolled subjects with genetic frontotemporal dementia, who constitute an ideal population for testing because their pathology is already known based on their mutation. Ten participants (three with symptomatic P301L and R406W MAPT mutations expected to show tau binding, three with presymptomatic MAPT mutations and four with non-tau mutations who acted as disease controls) underwent clinical characterization, tau-PET scanning with 18F-MK-6240, amyloid-PET imaging with 18F-NAV-4694 to rule out confounding Alzheimer's pathology, and high-resolution structural MRI. Tau-PET scans of all three symptomatic MAPT carriers demonstrated at least mild 18F-MK-6240 binding in expected regions, with particularly strong binding in a subject with an R406W MAPT mutation (known to be associated with Alzheimer's like neurofibrillary tangles). Two asymptomatic MAPT carriers estimated to be 5 years from disease onset both showed modest 18F-MK-6240 binding, while one ~30 years from disease onset did not exhibit any binding. Additionally, four individuals with symptomatic frontotemporal dementia caused by a non-tau mutation were scanned (two C9orf72; one GRN; one VCP): 18F-MK-6240 scans were negative for three subjects, while one advanced C9orf72 case showed minimal regionally non-specific binding. All 10 amyloid-PET scans were negative. Furthermore, a general linear model contrasting genetic frontotemporal dementia subjects to a set of 83 age-matched controls showed significant binding only in the MAPT carriers in selected frontal, temporal and subcortical regions. In summary, our findings demonstrate mild but significant binding of MK-6240 in amyloid-negative P301L and R406W MAPT mutation subjects, with higher standardized uptake value ratio in the R406W mutation associated with the presence of NFTs, and little non-specific binding. These results highlight that a positive 18F-MK-6240 tau-PET does not necessarily imply a diagnosis of Alzheimer's disease and point towards a potential use for 18F-MK-6240 as a biomarker in certain tauopathies beyond Alzheimer's, although further patient recruitment and autopsy studies will be necessary to determine clinical applicability.
34664612	12	15	tau	Gene	4137
34664612	31	54	frontotemporal dementia	Disease	MESH:D057180
34664612	56	59	Tau	Gene	4137
34664612	103	126	frontotemporal dementia	Disease	MESH:D057180
34664612	169	176	patient	Species	9606
34664612	245	248	tau	Gene	4137
34664612	260	283	frontotemporal dementia	Disease	MESH:D057180
34664612	364	375	18F-MK-6240	Chemical	-
34664612	398	401	tau	Gene	4137
34664612	421	444	frontotemporal dementia	Disease	MESH:D057180
34664612	480	503	frontotemporal dementia	Disease	MESH:D057180
34664612	659	664	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:1;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
34664612	669	674	R406W	ProteinMutation	tmVar:p|SUB|R|406|W;HGVS:p.R406W;VariantGroup:0;CorrespondingGene:4137;RS#:63750424;CorrespondingSpecies:9606;CA#:225495
34664612	675	679	MAPT	Gene	4137
34664612	707	710	tau	Gene	4137
34664612	746	750	MAPT	Gene	4137
34664612	779	782	tau	Gene	4137
34664612	861	864	tau	Gene	4137
34664612	883	894	18F-MK-6240	Chemical	-
34664612	896	903	amyloid	Disease	MESH:C000718787
34664612	921	933	18F-NAV-4694	Chemical	-
34664612	958	979	Alzheimer's pathology	Disease	MESH:D000544
34664612	1017	1020	Tau	Gene	4137
34664612	1056	1060	MAPT	Gene	4137
34664612	1097	1108	18F-MK-6240	Chemical	-
34664612	1192	1197	R406W	ProteinMutation	tmVar:p|SUB|R|406|W;HGVS:p.R406W;VariantGroup:0;CorrespondingGene:4137;RS#:63750424;CorrespondingSpecies:9606;CA#:225495
34664612	1198	1202	MAPT	Gene	4137
34664612	1241	1257	Alzheimer's like	Disease	MESH:D000544
34664612	1258	1281	neurofibrillary tangles	Disease	MESH:D055956
34664612	1301	1305	MAPT	Gene	4137
34664612	1377	1388	18F-MK-6240	Chemical	-
34664612	1514	1537	frontotemporal dementia	Disease	MESH:D057180
34664612	1554	1557	tau	Gene	4137
34664612	1585	1592	C9orf72	Gene	203228
34664612	1598	1601	GRN	Gene	2896
34664612	1607	1610	VCP	Gene	7415
34664612	1613	1624	18F-MK-6240	Chemical	-
34664612	1684	1691	C9orf72	Gene	203228
34664612	1752	1759	amyloid	Disease	MESH:C000718787
34664612	1841	1864	frontotemporal dementia	Disease	MESH:D057180
34664612	1949	1953	MAPT	Gene	4137
34664612	2087	2094	MK-6240	Chemical	MESH:C000618291
34664612	2098	2105	amyloid	Disease	MESH:C000718787
34664612	2115	2120	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:1;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
34664612	2125	2130	R406W	ProteinMutation	tmVar:p|SUB|R|406|W;HGVS:p.R406W;VariantGroup:0;CorrespondingGene:4137;RS#:63750424;CorrespondingSpecies:9606;CA#:225495
34664612	2131	2135	MAPT	Gene	4137
34664612	2206	2211	R406W	ProteinMutation	tmVar:p|SUB|R|406|W;HGVS:p.R406W;VariantGroup:0;CorrespondingGene:4137;RS#:63750424;CorrespondingSpecies:9606;CA#:225495
34664612	2253	2257	NFTs	Disease	
34664612	2344	2347	tau	Gene	4137
34664612	2394	2413	Alzheimer's disease	Disease	MESH:D000544
34664612	2452	2463	18F-MK-6240	Chemical	-
34664612	2490	2501	tauopathies	Disease	MESH:D024801
34664612	2509	2520	Alzheimer's	Disease	MESH:D000544
34664612	2539	2546	patient	Species	9606
34664612	Association	MESH:C000618291	RS#:63750424;HGVS:p.R406W;CorrespondingGene:4137
34664612	Association	MESH:C000618291	RS#:63751273;HGVS:p.P301L;CorrespondingGene:4137
34664612	Association	MESH:D057180	RS#:63750424;HGVS:p.R406W;CorrespondingGene:4137
34664612	Association	MESH:D055956	RS#:63751273;HGVS:p.P301L;CorrespondingGene:4137
34664612	Association	MESH:D055956	RS#:63750424;HGVS:p.R406W;CorrespondingGene:4137
34664612	Association	MESH:D057180	RS#:63751273;HGVS:p.P301L;CorrespondingGene:4137
34664612	Association	MESH:D000544	RS#:63750424;HGVS:p.R406W;CorrespondingGene:4137
34664612	Association	MESH:D057180	2896
34664612	Association	MESH:D055956	4137
34664612	Association	MESH:D000544	RS#:63751273;HGVS:p.P301L;CorrespondingGene:4137
34664612	Association	MESH:D057180	4137
34664612	Association	MESH:D057180	7415
34664612	Positive_Correlation	MESH:D057180	203228
34664612	Association	MESH:D000544	4137
34664612	Bind	2896	4137
34664612	Association	MESH:D024801	4137
34664612	Bind	MESH:C000618291	4137
34664612	Association	MESH:D057180	4137
34664612	Association	MESH:D055956	4137
34664612	Association	MESH:D000544	4137

